Literature DB >> 17684318

Psychosocial approach to endocrine disease.

Nicoletta Sonino1, Elena Tomba, Giovanni A Fava.   

Abstract

In recent years, there has been growing interest in the psychosocial aspects of endocrine disease, such as the role of life stress in the pathogenesis of some conditions, their association with affective disorders, and the presence of residual symptoms after adequate treatment. In clinical endocrinology, exploration of psychosocial antecedents may elucidate the temporal relationships between life events and symptom onset, as it has been shown to be relevant for pituitary (Cushing's disease, hyperprolactinemia) or thyroid (Graves' disease) conditions, as well as the role of allostatic load, linked to chronic stress, in uncovering a person's vulnerability. After endocrine abnormalities are established, they are frequently associated with a wide range of psychological symptoms: at times, such symptoms reach the level of psychiatric illness (mainly mood and anxiety disorders); at other times, however, they can only be identified by the subclinical forms of assessment provided by the Diagnostic Criteria for Psychosomatic Research (DCPR). Indeed, in a population study, the majority of patients suffered from at least one of the three DCPR syndromes considered: irritable mood, demoralization, persistent somatization. In particular, irritable mood was found to occur in 46% of 146 patients successfully treated for endocrine conditions, a rate similar to that found in cardiology and higher than in oncology and gastroenterology. Long-standing endocrine disorders may imply a degree of irreversibility of the pathological process and induce highly individualized affective responses. In patients who showed persistence or even worsening of psychological distress upon proper endocrine treatment, the value of appropriate psychiatric interventions was underscored. As it happened in other fields of clinical medicine, a conceptual shift from a merely biomedical care to a psychosomatic consideration of the person and his/her quality of life appears to be necessary for improving effectiveness in endocrinology. The DCPR have been demonstrated to be a valuable tool for psychological assessment in the various phases of endocrine disease from diagnostic to follow-up periods.

Entities:  

Mesh:

Year:  2007        PMID: 17684318     DOI: 10.1159/000106795

Source DB:  PubMed          Journal:  Adv Psychosom Med        ISSN: 0065-3268


  5 in total

Review 1.  Psychosomatic medicine is a comprehensive field, not a synonym for consultation liaison psychiatry.

Authors:  Giovanni Andrea Fava; Carlotta Belaise; Nicoletta Sonino
Journal:  Curr Psychiatry Rep       Date:  2010-06       Impact factor: 5.285

Review 2.  Antidepressant-induced hyperprolactinaemia: incidence, mechanisms and management.

Authors:  Flora Coker; David Taylor
Journal:  CNS Drugs       Date:  2010-07       Impact factor: 5.749

Review 3.  Management of psychosis associated with a prolactinoma: case report and review of the literature.

Authors:  Shirin Ali; Karen Klahr Miller; Oliver Freudenreich
Journal:  Psychosomatics       Date:  2010 Sep-Oct       Impact factor: 2.386

4.  Thyroxine, shape, and weight: interaction of Graves' disease and bulimia nervosa.

Authors:  Martin Teufel; Katrin Elisabeth Giel; Jule Lehr; Sandra Becker; Michaela Muthig; Stephan Zipfel; Jürgen Kuprion
Journal:  Eat Weight Disord       Date:  2013-03-29       Impact factor: 4.652

5.  Development of a visual tool to assess six dimensions of health and its validation in patients with endocrine disorders.

Authors:  Christian Fazekas; Dennis Linder; Franziska Matzer; Christian Vajda; Alexander Avian; Verena Theiler-Schwetz; Christian Trummer; Julia Došen; Jelena Rokvic; Marco Mohl; Stefan Pilz
Journal:  Wien Klin Wochenschr       Date:  2021-02-04       Impact factor: 2.275

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.